We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$126B
AUM Growth
+$7.85B
(+6.6%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
35.91%
Holding
339
New
8
Increased
67
Reduced
188
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$171M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$157M |
| 3 |
New Fortress Energy
NFE
|
+$100M |
| 4 |
Alibaba
BABA
|
+$70.3M |
| 5 |
Boeing
BA
|
+$64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$1.33B |
| 2 |
Eli Lilly
LLY
|
+$504M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$432M |
| 4 |
Novartis
NVS
|
+$163M |
| 5 |
JPMorgan Chase
JPM
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Healthcare | 30.82% |
| 3 | Industrials | 11.15% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Financials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Raymond James Financial
RJF
$34B
| $1.37B | 1.09% |
12,317,607
-251,520
| -2% | -$25.9M |
|
|
27
Novartis
NVS
$297B
| $1.3B | 1.03% |
12,905,697
-1,689,455
| -12% | -$163M |
|
28
NetApp
NTAP
$37.2B
| $1.3B | 1.03% |
14,709,824
-530,990
| -3% | -$42.7M |
|
29
Aecom
ACM
$9.75B
| $1.29B | 1.03% |
14,009,719
-575,660
| -4% | -$48.9M |
|
30
NVIDIA
NVDA
$5.42T
| $1.28B | 1.01% |
25,767,300
-114,650
| -0.4% | -$5.31M |
|
31
TJX Companies
TJX
$178B
| $1.27B | 1% |
13,491,848
-75,800
| -0.6% | -$6.8M |
|
|
32
Bristol-Myers Squibb
BMY
$132B
| $1.21B | 0.96% |
23,534,378
+2,998,228
| +15% | +$157M |
|
|
HES
33
DELISTED
Hess
HES
| $1.15B | 0.91% |
7,970,450
-136,385
| -2% | -$20M |
|
34
Baidu
BIDU
$37.2B
| $1.11B | 0.88% |
9,283,034
+12,480
| +0.1% | +$1.44M |
|
35
Intuit
INTU
$89B
| $1.09B | 0.86% |
1,736,031
-21,455
| -1% | -$11.8M |
|
|
PXD
36
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.07B | 0.85% |
4,760,256
-86,100
| -2% | -$20.2M |
|
37
Visa
V
$677B
| $1.05B | 0.83% |
4,046,151
+5,820
| +0.1% | +$1.43M |
|
38
United Airlines
UAL
$42.1B
| $964M | 0.76% |
23,353,324
-116,110
| -0.5% | -$4.57M |
|
|
ONC
39
BeOne Medicines Ltd
ONC
$39.4B
| $900M | 0.71% |
4,988,639
-20,100
| -0.4% | -$3.64M |
|
40
Delta Air Lines
DAL
$60.1B
| $893M | 0.71% |
22,199,858
-49,910
| -0.2% | -$1.81M |
|
41
Jacobs Solutions
J
$17B
| $791M | 0.63% |
7,371,213
-154,174
| -2% | -$16.8M |
|
42
Mattel
MAT
$4.23B
| $777M | 0.62% |
41,178,489
-438,300
| -1% | -$8.53M |
|
43
Royal Caribbean
RCL
$85.6B
| $777M | 0.62% |
6,001,561
-190,300
| -3% | -$19.4M |
|
|
44
JPMorgan Chase
JPM
$950B
| $770M | 0.61% |
4,524,046
-824,900
| -15% | -$125M |
|
45
Elanco Animal Health
ELAN
$11.1B
| $754M | 0.6% |
50,600,324
+1,431,665
| +3% | +$16.2M |
|
46
Qualcomm
QCOM
$176B
| $754M | 0.6% |
5,211,042
-681,455
| -12% | -$84.4M |
|
47
Analog Devices
ADI
$190B
| $726M | 0.57% |
3,656,705
-46,080
| -1% | -$8.23M |
|
48
Amazon
AMZN
$2.96T
| $657M | 0.52% |
4,325,350
+17,000
| +0.4% | +$2.38M |
|
49
HP
HPQ
$27.5B
| $626M | 0.5% |
20,801,915
+35,240
| +0.2% | +$987K |
|
50
Zimmer Biomet
ZBH
$18.4B
| $619M | 0.49% |
5,086,578
+484,151
| +11% | +$54M |
|
Similar funds
VAM
Primecap Management's Q4 2023 Portfolio in Review
As of Q4 2023, Primecap Management held 339 positions worth $126B, up 6.6% from $118B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.8%. Primecap Management opened 8 new positions and exited 5, leaving the 339-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2023 buy was Boeing: 299,300 shares worth $78M.
- Primecap Management added most to Albemarle in Q4 2023, an estimated $171M increase.
- Primecap Management's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $504M.
- Primecap Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $1.33B.
- Primecap Management's ten largest holdings make up 36% of its $126B portfolio in Q4 2023.
- Primecap Management opened 8 new positions and closed 5 in Q4 2023.
- Primecap Management's portfolio value rose 6.6% quarter-over-quarter to $126B.
Based on Primecap Management's 13F filing for Q4 2023, filed 9 Feb 2024.